Related Experiment Video
Updated: May 23, 2026
11:11
Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment
Published on: January 24, 2020
New adoptive immunotherapy strategies for solid tumours with CIK cells
Sharmilan Thanendrarajan1, Young Kim, Ingo Schmidt-Wolf
1Department of Internal Medicine III, University of Bonn, Bonn, Germany. Ingo.Schmidt-Wolf@ukb.uni-bonn.de
Expert Opinion on Biological Therapy
|March 27, 2012
Summary
Cytokine-induced killer (CIK) cells show promise in cancer treatment. Combining CIK cell therapy with conventional treatments offers an innovative approach for improved patient outcomes.
Area of Science:
- Immunology
- Oncology
- Cell Therapy
Background:
- Malignant diseases often have poor prognoses despite new drug development.
- Cytokine-induced killer (CIK) cells have emerged as a significant advancement in cancer treatment.
Purpose of the Study:
- To review recent progress in adoptive immunotherapy for cancer using CIK cells.
- To summarize the current state of CIK cell application in oncology.
Main Methods:
- A selective literature search was conducted.
- The review synthesizes findings on CIK cell-based adoptive immunotherapy.
Main Results:
- CIK cell adoptive immunotherapy is a valuable tool in cancer management.
- Recent advances highlight the potential of CIK cells in enhancing treatment efficacy.
Conclusions:
- CIK cells play a crucial role in modern cancer therapy.
- Integrating CIK cells with established treatments is an innovative strategy.
- This combination approach may offer new directions for future cancer treatment research.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...